On March 9, 2016, the U.S. Food and Drug Administration (FDA) approved the first generic version of Pfizer Inc.’s Viagra. Law360 reports that Teva Pharmaceutical Industries Ltd.’s abbreviated 25-, 50- and 100-milligram sildenafil citrate tablets were all approved and the company will have market exclusivity for the next 180 days. However, due to a 12-day bench trial in 2011 where Pfizer sued Teva to enforce its patent, the generic could not be sold until the patent expired in 2019 or until permitted by the licensing agreement. According to CBS News and RAPS.org Teva will begin selling the drug Dec. 11, 2017. RAPS.org ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.